Advanced search
Publication Cover
Cell Cycle Volume 13, 2014 - Issue 5
Submit an article Journal homepage
846
Views
19
CrossRef citations to date
0
Altmetric
Editorials: Cell Cycle Features

BRD4: A BET(ter) target for the treatment of AML?

Peter Valent Ludwig Boltzmann Cluster Oncology; Medical University of Vienna; Vienna, Austria; Department of Internal Medicine I; Division of Hematology & Hemostaseology; Medical University of Vienna; Vienna, AustriaCorrespondence[email protected]
&
Johannes Zuber Research Institute of Molecular Pathology (IMP); Vienna, Austria
Pages 689-690 | Received 24 Sep 2013, Accepted 28 Oct 2013, Published online: 21 Jan 2014
 
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days
"BRD4: A BET(ter) target for the treatment of AML?." Cell Cycle, 13(5), pp. 689–690

Related Research Data

Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia.
Source: American Society of Hematology
Digging deep into “dirty” drugs – modulation of the methylation machinery
Source: Informa UK Limited

Linking provided by 
Download PDF

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.